Ferroptosis in hepatocellular carcinoma: from bench to bedside.

Hepatology

Department of Surgery, UT Southwestern Medical Center, Dallas, Texas, USA.

Published: September 2024

The most widespread type of liver cancer, HCC, is associated with disabled cellular death pathways. Despite therapeutic advancements, resistance to current systemic treatments (including sorafenib) compromises the prognosis of patients with HCC, driving the search for agents that might target novel cell death pathways. Ferroptosis, a form of iron-mediated nonapoptotic cell death, has gained considerable attention as a potential target for cancer therapy, especially in HCC. The role of ferroptosis in HCC is complex and diverse. On one hand, ferroptosis can contribute to the progression of HCC through its involvement in both acute and chronic liver conditions. In contrast, having ferroptosis affect HCC cells might be desirable. This review examines the role of ferroptosis in HCC from cellular, animal, and human perspectives while examining its mechanisms, regulation, biomarkers, and clinical implications.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551055PMC
http://dx.doi.org/10.1097/HEP.0000000000000390DOI Listing

Publication Analysis

Top Keywords

death pathways
8
cell death
8
role ferroptosis
8
ferroptosis hcc
8
hcc
7
ferroptosis
6
ferroptosis hepatocellular
4
hepatocellular carcinoma
4
carcinoma bench
4
bench bedside
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!